Rethinking Diabetes: A Weekly Review
Malattie Metaboliche e Diabetologia
Diabetes Management and Complications: Latest Research Insights
This episode explores the latest research on diabetes complications and management, covering retinopathy progression, laboratory guidelines, closed-loop systems, microvascular complications, foot ulcers, gut microbiota, environmental factors, metformin's effects, bariatric surgery outcomes, and pharmacotherapy comparisons.
Accedi o Registrati per ascoltare questo episodio
Bibliografia
1. Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.
Authors: Perais J, Agarwal R, Evans JR, et al.
Journal: The Cochrane database of systematic reviews, 2023 Feb 22
PMID: 36815723
DOI: 10.1002/14651858.CD013775.pub2
2. Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus.
Authors: Sacks DB, Arnold M, Bakris GL, et al.
Journal: Diabetes care, 2023 Oct 1
PMID: 37471273
DOI: 10.2337/dci23-0036
3. Hybrid closed-loop systems for managing blood glucose levels in type 1 diabetes: a systematic review and economic modelling.
Authors: Asgharzadeh A, Patel M, Connock M, et al.
Journal: Health technology assessment (Winchester, England), 2024 Dec
PMID: 39673446
DOI: 10.3310/JYPL3536
4. Prevention of Microvascular Complications of Diabetes.
Authors: Crasto W, Patel V, Davies MJ, et al.
Journal: Endocrinology and metabolism clinics of North America, 2021 Sep
PMID: 34399955
DOI: 10.1016/j.ecl.2021.05.005
5. Mechanisms of diabetic foot ulceration: A review.
Authors: Deng H, Li B, Shen Q, et al.
Journal: Journal of diabetes, 2023 Apr
PMID: 36891783
DOI: 10.1111/1753-0407.13372
6. Gut microbiota and the early prevention window in type 1 diabetes and latent autoimmune diabetes in adults: a state-of-the-art narrative review on diet and metabolites.
Authors: Kaminska H, Wieczorek W, Pruc M, et al.
Journal: Frontiers in endocrinology, 2026
PMID: 42181191
DOI: 10.3389/fendo.2026.1837746
7. Do We Have Enough Evidence That Metformin Is Superior to Other Antidiabetic Drugs in Pancreatic Cancer Risk Reduction?
Authors: Szymczak-Pajor I, Drzewoski J, Wenclewska S, et al.
Journal: International journal of molecular sciences, 2026 May 8
PMID: 42196179
DOI: 10.3390/ijms27104195
8. Effect of Laparoscopic Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass on Weight Loss, Comorbidities, and Reflux at 10 Years in Adult Patients With Obesity: The SLEEVEPASS Randomized Clinical Trial.
Authors: Salminen P, Grönroos S, Helmiö M, et al.
Journal: JAMA surgery, 2022 Aug 1
PMID: 35731535
DOI: 10.1001/jamasurg.2022.2229
9. Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials.
Authors: Palmer SC, Tendal B, Mustafa RA, et al.
Journal: BMJ (Clinical research ed.), 2021 Jan 13
PMID: 33441402
DOI: 10.1136/bmj.m4573
10. Decoding the exposome for type 1 diabetes prevention: A scoping review of environmental determinants.
Authors: Rollet M, Aguayo GA, Canha D, et al.
Journal: Diabetes & metabolism, 2026 May
PMID: 41905461
DOI: 10.1016/j.diabet.2026.101756
Authors: Perais J, Agarwal R, Evans JR, et al.
Journal: The Cochrane database of systematic reviews, 2023 Feb 22
PMID: 36815723
DOI: 10.1002/14651858.CD013775.pub2
2. Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus.
Authors: Sacks DB, Arnold M, Bakris GL, et al.
Journal: Diabetes care, 2023 Oct 1
PMID: 37471273
DOI: 10.2337/dci23-0036
3. Hybrid closed-loop systems for managing blood glucose levels in type 1 diabetes: a systematic review and economic modelling.
Authors: Asgharzadeh A, Patel M, Connock M, et al.
Journal: Health technology assessment (Winchester, England), 2024 Dec
PMID: 39673446
DOI: 10.3310/JYPL3536
4. Prevention of Microvascular Complications of Diabetes.
Authors: Crasto W, Patel V, Davies MJ, et al.
Journal: Endocrinology and metabolism clinics of North America, 2021 Sep
PMID: 34399955
DOI: 10.1016/j.ecl.2021.05.005
5. Mechanisms of diabetic foot ulceration: A review.
Authors: Deng H, Li B, Shen Q, et al.
Journal: Journal of diabetes, 2023 Apr
PMID: 36891783
DOI: 10.1111/1753-0407.13372
6. Gut microbiota and the early prevention window in type 1 diabetes and latent autoimmune diabetes in adults: a state-of-the-art narrative review on diet and metabolites.
Authors: Kaminska H, Wieczorek W, Pruc M, et al.
Journal: Frontiers in endocrinology, 2026
PMID: 42181191
DOI: 10.3389/fendo.2026.1837746
7. Do We Have Enough Evidence That Metformin Is Superior to Other Antidiabetic Drugs in Pancreatic Cancer Risk Reduction?
Authors: Szymczak-Pajor I, Drzewoski J, Wenclewska S, et al.
Journal: International journal of molecular sciences, 2026 May 8
PMID: 42196179
DOI: 10.3390/ijms27104195
8. Effect of Laparoscopic Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass on Weight Loss, Comorbidities, and Reflux at 10 Years in Adult Patients With Obesity: The SLEEVEPASS Randomized Clinical Trial.
Authors: Salminen P, Grönroos S, Helmiö M, et al.
Journal: JAMA surgery, 2022 Aug 1
PMID: 35731535
DOI: 10.1001/jamasurg.2022.2229
9. Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials.
Authors: Palmer SC, Tendal B, Mustafa RA, et al.
Journal: BMJ (Clinical research ed.), 2021 Jan 13
PMID: 33441402
DOI: 10.1136/bmj.m4573
10. Decoding the exposome for type 1 diabetes prevention: A scoping review of environmental determinants.
Authors: Rollet M, Aguayo GA, Canha D, et al.
Journal: Diabetes & metabolism, 2026 May
PMID: 41905461
DOI: 10.1016/j.diabet.2026.101756
